Novartis Ag (NVSEF) Non-cash Items (2009 - 2025)

Novartis Ag has disclosed Non-cash Items across 9 years of filings, most recently posting $3.0 billion for Q2 2025.

• Non-cash Items for Q2 2025 came in at $3.0 billion, up 23.08% year-over-year; the trailing twelve-month figure through Jun 2025 was $3.0 billion (up 23.08% YoY), and the FY2025 annual result was $11.2 billion, up 129.3% from the prior year.
• Non-cash Items came in at $3.0 billion for Q2 2025 at Novartis Ag, down from $4.9 billion in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $5.4 billion in Q4 2022 to a low of $1.9 billion in Q2 2021.
• The 5-year median for Non-cash Items is $3.1 billion (2022), against an average of $3.6 billion.
• Across the five-year window, Non-cash Items dropped 18.98% in 2021 and surged 61.11% in 2022, its largest moves.
• Novartis Ag's Non-cash Items stood at $4.3 billion in 2021, then advanced by 26.91% to $5.4 billion in 2022, then fell by 3.05% to $5.2 billion in 2023, then retreated by 6.71% to $4.9 billion in 2024, then sank by 39.68% to $3.0 billion in 2025.
• The last three Non-cash Items figures came in at $3.0 billion (Q2 2025), $4.9 billion (Q4 2024), and $2.4 billion (Q2 2024), per Business Quant data.